Effective for the fall 2024 semester, the College of Pharmacy International Biomedical Regulatory Sciences (IBRS) program will offer a new online Master of Science degree in Pharmacy, with an area of emphasis in Clinical Trials Management (MS-CTM). This is the second master’s degree IBRS will administer, expanding the program’s offerings beyond its longstanding regulatory sciences graduate degree and its four graduate certificate programs.

“We continue to see growth in the number of students interested in career opportunities in regulatory affairs and clinical research, operations, and monitoring, especially among our Doctor of Pharmacy students. We anticipate that MS-CTM will be of interest to other students in healthcare, such as nursing and public health,” said Dr. Grace Gowda, MPharm, PhD, RAC, Director of the IBRS Program. “This new degree will allow students and working professionals to learn the essential skills and knowledge necessary to work in the complex and highly regulated medical industry, and the design of the graduate degree makes it approachable and flexible for all.”

Consisting of just 33 credits of coursework, the degree is administered in an online, asynchronous format that allows learners to engage in other full-time work or studies alongside their MS-CTM coursework. The MS-CTM is a non-thesis degree, meaning students complete an applied project of their choice as their capstone experience, which is integrated into the degree as one of the required eight core classes.

These classes include:

• PHAR 7100E: Biostatistical Applications for the Pharmaceutical and Biotechnology Industries (3 credit hours)
• PHAR 6010E: Pharmaceutical, Biotechnology, and Device Industries (4 credit hours)
• PHAR 6030E: Current Good Manufacturing Practices (4 credit hours)
• PHAR 6140E: Overview of Drug Safety Throughout Medical Product Lifecycle (4 credit hours)
• PHAR 6200E: Clinical Trials Design and Monitoring (4 credit hours)
• PHAR 6210E: Project Management in Clinical Trials (3 credit hours)
• PHAR 6310E: Good Clinical Practice Regulations for Drugs, Biologic Products, and Medical Devices (3 credit hours)
• PHAR 6950E: Master’s Seminar in Regulatory Affairs (3 credit hours)
• PHRM 7230E: Ethical Issues in Research (3 credit hours)

Students also will take at least five credit hours of electives—with options ranging from Food and Drug Law to European Pharmaceutical and Biologics Regulatory Sciences—to satisfy the degree requirements. The application deadline for the fall 2024 semester for domestic students is June 1. Interested students can learn more and apply here.